NasdaqGS - Nasdaq Real Time Price USD

ACV Auctions Inc. (ACVA)

17.72 -0.24 (-1.34%)
At close: April 25 at 4:00 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1091010
Avg. Estimate -0.09-0.07-0.340.09
Low Estimate -0.1-0.08-0.36-0.07
High Estimate -0.08-0.04-0.290.43
Year Ago EPS -0.11-0.1-0.47-0.34

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 13131313
Avg. Estimate 143.96M158.41M612.91M774.56M
Low Estimate 141.99M150.06M596.96M712.82M
High Estimate 145.71M171M619.48M832M
Year Ago Sales 119.63M124.22M481.23M612.91M
Sales Growth (year/est) 20.30%27.50%27.40%26.40%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. -0.16-0.14-0.14-0.15
EPS Actual -0.11-0.1-0.11-0.14
Difference 0.050.040.030.01
Surprise % 31.20%28.60%21.40%6.70%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.09-0.07-0.340.09
7 Days Ago -0.09-0.07-0.340.09
30 Days Ago -0.09-0.07-0.340.06
60 Days Ago -0.09-0.07-0.320.08
90 Days Ago -0.07-0.06-0.270.14

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days ----1--
Up Last 30 Days ----11
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD ACVAIndustrySectorS&P 500
Current Qtr. 18.20%----2.60%
Next Qtr. 30.00%----13.40%
Current Year 27.70%----5.20%
Next Year 126.50%----13.30%
Next 5 Years (per annum) 0.80%----11.11%
Past 5 Years (per annum) --------

Research Analysis

Analyst Price Targets

15.00 Low
21.75 Average
17.72 Current
28.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Reiterates JMP Securities: Market Outperform to Market Outperform 4/17/2024
Maintains JMP Securities: Market Outperform to Market Outperform 1/16/2024
Upgrade Northcoast Research: Neutral to Buy 1/10/2024
Reiterates Needham: Buy to Buy 11/7/2023
Maintains Guggenheim: Buy to Buy 8/9/2023
Reiterates Barrington Research: Outperform to Outperform 8/8/2023

Related Tickers